| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCRESAHA.113.301209 |
| P698 | PubMed publication ID | 23743335 |
| P50 | author | Issei Komuro | Q17158369 |
| Toshimitsu Hamasaki | Q40812240 | ||
| Shinichiro Suna | Q114328008 | ||
| Yasuhiko Sakata | Q114328009 | ||
| Daisaku Nakatani | Q125294703 | ||
| Sen Matsumoto | Q125294914 | ||
| Masaya Usami | Q125296016 | ||
| P2093 | author name string | Tetsuhisa Kitamura | |
| Shinsuke Nanto | |||
| Masahiko Hara | |||
| Yukio Kawahara | |||
| P2860 | cites work | Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development | Q24628811 |
| P433 | issue | 3 | |
| P921 | main subject | myocardial infarction | Q12152 |
| heart failure | Q181754 | ||
| microRNA | Q310899 | ||
| P304 | page(s) | 322-326 | |
| P577 | publication date | 2013-06-06 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction | |
| P478 | volume | 113 |
| Q60907434 | A Specific Circulating MicroRNA Cluster Is Associated to Late Differential Cardiac Response to Doxorubicin-Induced Cardiotoxicity |
| Q33874015 | Acute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular Injury |
| Q98159664 | Advances in Exosomes Derived from Different Cell Sources and Cardiovascular Diseases |
| Q39411678 | Ankyrin Repeat Domain 1 Protein: A Functionally Pleiotropic Protein with Cardiac Biomarker Potential |
| Q98196677 | Application of exosomes as liquid biopsy in clinical diagnosis |
| Q92853263 | Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis |
| Q42212696 | CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells. |
| Q92191078 | Cardiac Fibroblasts and Cardiac Fibrosis: Precise Role of Exosomes |
| Q89666087 | Cardioprotection and Thyroid Hormones in the Clinical Setting of Heart Failure |
| Q48653724 | Circulating Exosomes in Cardiovascular Diseases |
| Q52348496 | Circulating Plasma MicroRNA-208a as Potential Biomarker of Chronic Indeterminate Phase of Chagas Disease. |
| Q64953291 | Circulating exosomal miR-92b-5p is a promising diagnostic biomarker of heart failure with reduced ejection fraction patients hospitalized for acute heart failure. |
| Q51747176 | Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator. |
| Q33580495 | Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction |
| Q58700390 | Circulating microRNAs -192 and -194 are associated with the presence and incidence of diabetes mellitus |
| Q27001706 | Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire? |
| Q42938724 | Circulating p53-responsive microRNAs as predictive biomarkers in heart failure after acute myocardial infarction: the long and arduous road from scientific discovery to clinical utility |
| Q38756838 | Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives. |
| Q38670276 | Comparison of the release of microRNAs and extracellular vesicles from platelets in response to different agonists |
| Q33881021 | Computational prediction of disease microRNAs in domestic animals |
| Q36003227 | Coronary Artery-Bypass-Graft Surgery Increases the Plasma Concentration of Exosomes Carrying a Cargo of Cardiac MicroRNAs: An Example of Exosome Trafficking Out of the Human Heart with Potential for Cardiac Biomarker Discovery |
| Q33816471 | Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients |
| Q33989539 | Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome |
| Q26744498 | Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress |
| Q64233463 | Different expression of Micro RNA-126, 133a and 145 in aorta and saphenous vein samples of patients undergoing coronary artery bypass graft surgery |
| Q30251632 | Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches |
| Q38667736 | Exosomal miRNAs in Heart Disease |
| Q91027293 | Exosomal non-coding RNAs (Exo-ncRNAs) in cardiovascular health |
| Q38304096 | Exosome and its roles in cardiovascular diseases |
| Q64246035 | Exosome in Cardiovascular Diseases: A Complex World Full of Hope |
| Q47446325 | Exosomes Mediate the Beneficial Effects of Exercise |
| Q49942942 | Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases |
| Q45974468 | Exosomes as agents of change in the cardiovascular system. |
| Q28081616 | Exosomes for Intramyocardial Intercellular Communication |
| Q90599368 | Exosomes in Coronary Artery Disease |
| Q38264347 | Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle. |
| Q49942926 | Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases |
| Q41001027 | Exosomes: A Rising Star in Falling Hearts |
| Q39395324 | Exosomes: promising sacks for treating ischemic heart disease? |
| Q90401953 | Expression of miRNAs-122, -192 and -499 in end stage renal disease associated with acute myocardial infarction |
| Q94465774 | Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure |
| Q89433754 | Extracellular Vesicles and the Application of System Biology and Computational Modeling in Cardiac Repair |
| Q91656644 | Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers |
| Q49196893 | Extracellular Vesicles in Cardiovascular Theranostics. |
| Q38271960 | Extracellular Vesicles in Heart Disease: Excitement for the Future ? |
| Q38569438 | Extracellular vesicle microRNAs: biomarker discovery in various diseases based on RT-qPCR. |
| Q38430673 | Extracellular vesicles and atherosclerotic disease |
| Q39115035 | Extracellular vesicles in coronary artery disease. |
| Q46268171 | Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. |
| Q38531858 | Gene Expression Signatures and the Spectrum of Coronary Artery Disease |
| Q91173597 | Hepatocyte-derived exosomal MiR-194 activates PMVECs and promotes angiogenesis in hepatopulmonary syndrome |
| Q38170524 | Human diseases caused by germline and somatic abnormalities in microRNA and microRNA-related genes |
| Q46155121 | Identification and Evaluation of Novel MicroRNA Biomarkers in Plasma and Feces Associated with Drug-induced Intestinal Toxicity |
| Q38939910 | Identification of FLOT2 as a novel target for microRNA-34a in melanoma |
| Q35849561 | Identification of General and Heart-Specific miRNAs in Sheep (Ovis aries) |
| Q37660550 | Implications of dynamic changes in miR-192 expression in ischemic acute kidney injury |
| Q54963943 | In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction. |
| Q33763532 | In silico identification of plant miRNAs in mammalian breast milk exosomes--a small step forward? |
| Q38874295 | Integrated analysis of mRNA and miRNA expression in response to interleukin-6 in hepatocytes. |
| Q39109413 | Ischemia/Reperfusion |
| Q92840438 | Lichen extracts regulate the expression of BMP7 via miR-194-5p targeting to decrease the risk atrial fibrillation |
| Q36615801 | Loss of CEACAM1, a Tumor-Associated Factor, Attenuates Post-infarction Cardiac Remodeling by Inhibiting Apoptosis |
| Q61811681 | Metabolic Alterations in Cardiopulmonary Vascular Dysfunction |
| Q92531945 | Micro RNA-192 Is Negatively Associated With Cardiovascular Events Among Wait-Listed Potential Kidney Transplant Recipients on Hemodialysis Over a 5-year Follow-up Period |
| Q26750638 | MicroRNA and Heart Failure |
| Q36626642 | MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction |
| Q37641769 | MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat. |
| Q91810467 | MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients-A Systematic Review |
| Q40026732 | MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes |
| Q28076541 | MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena? |
| Q37678442 | MicroRNAs in cardiac regeneration and cardiovascular disease |
| Q27024714 | MicroRNAs in heart failure: Small molecules with major impact |
| Q38730489 | MicroRNAs in heart failure: from biomarker to target for therapy |
| Q39304689 | MicroRNAs in injury and repair |
| Q35071551 | MicroRNAs: new biomarkers and therapeutic targets after cardiac arrest? |
| Q52642353 | Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides. |
| Q38837698 | Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives. |
| Q26999363 | Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease |
| Q88482868 | Non-coding RNAs as biomarkers for acute myocardial infarction |
| Q33897534 | Noncoding RNAs in vascular disease. |
| Q37503986 | Novel Biomarker MicroRNAs for Subtyping of Acute Coronary Syndrome: A Bioinformatics Approach. |
| Q28088373 | Novel methodologies for biomarker discovery in atherosclerosis |
| Q26746965 | Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis |
| Q46253112 | Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity. |
| Q28545216 | Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis |
| Q43964974 | Potential Role of Exosomes in Mending a Broken Heart: Nanoshuttles Propelling Future Clinical Therapeutics Forward. |
| Q104070079 | Precision medicine for heart failure based on molecular mechanisms The Research Achievement Award Lecture |
| Q41936990 | Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders. |
| Q51335950 | Prevalence of IgG Autoantibodies against GD3 Ganglioside in Acute Zika Virus Infection. |
| Q38584364 | Recent Developments in Heart Failure |
| Q26829774 | Recent developments in cardiovascular genetics and genomics |
| Q92757549 | Reconstruction of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in Cerebral Infarction |
| Q45069455 | Regulating MicroRNA Expression: At the Heart of Diabetes Mellitus and the Mitochondrion |
| Q64957921 | Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. |
| Q47929107 | Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients. |
| Q92218826 | Role of the Thyroid System in the Dynamic Complex Network of Cardioprotection |
| Q89496696 | Roles and Functions of Exosomal Non-coding RNAs in Vascular Aging |
| Q64102230 | Roles of Exosomes Derived From Immune Cells in Cardiovascular Diseases |
| Q38904719 | Roles of exosomes in cardioprotection |
| Q36135052 | Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells |
| Q48211539 | Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs |
| Q57161787 | Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases |
| Q55071721 | Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles. |
| Q38761212 | Stem cell therapy for ischemic heart diseases |
| Q58702281 | Stem cell-derived exosomes - an emerging tool for myocardial regeneration |
| Q35137389 | Studying the system-level involvement of microRNAs in Parkinson's disease |
| Q64086531 | Systems biology approaches to investigating the roles of extracellular vesicles in human diseases |
| Q59813054 | Targeting Non-coding RNA in Vascular Biology and Disease |
| Q92074867 | The Art of Intercellular Wireless Communications: Exosomes in Heart Disease and Therapy |
| Q61444355 | The Impact of Cardiac Lipotoxicity on Cardiac Function and Mirnas Signature in Obese and Non-Obese Rats with Myocardial Infarction |
| Q41995331 | The Multifaceted Functions of Exosomes in Health and Disease: An Overview. |
| Q59800931 | The Potential Roles of Extracellular Vesicles in Cigarette Smoke-Associated Diseases |
| Q58771019 | The Potential of Stem Cells and Stem Cell-Derived Exosomes in Treating Cardiovascular Diseases |
| Q36106421 | The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity. |
| Q35888026 | The biology of circulating microRNAs in cardiovascular disease. |
| Q57177487 | The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases |
| Q38786667 | The importance of p53 pathway genetics in inherited and somatic cancer genomes. |
| Q34356918 | The myriad essential roles of microRNAs in cardiovascular homeostasis and disease |
| Q38210767 | The p53/miR-34 axis in development and disease |
| Q38182139 | The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy. |
| Q38281750 | The war against heart failure: the Lancet lecture |
| Q38998171 | Thyroid hormones and cardiovascular disease |
| Q36922126 | Tiny Shuttles for Information Transfer: Exosomes in Cardiac Health and Disease |
| Q42176384 | Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue |
| Q51363751 | miR-192-5p mediates hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes via targeting of FABP3. |
| Q41856059 | miR199a-3p regulates P53 by targeting CABLES1 in mouse cardiac c-kit+ cells to promote proliferation and inhibit apoptosis through a negative feedback loop |
| Q28116054 | miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration |
| Q89019543 | miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges |
| Q33765415 | miRNAs as biomarkers for diagnosis of heart failure: A systematic review and meta-analysis |
| Q27028108 | miRNome in myocardial infarction: Future directions and perspective |
| Q38668253 | microRNAs in Cerebrovascular Disease. |
Search more.